I bet if you looked at the RAP prospectus prior to relisting you would find the same scenario. No revenue, most of the trials were done since relist, etc.
just saying you can't use RAP in its current status to compare to ePat pre listing.
I bet if you looked at the RAP prospectus prior to relisting you...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
